A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
AyoOluwa O. Olubamiwa's research focuses on drug-induced liver injury (DILI), a significant concern in pharmaceutical development and patient safety. Their work investigates the roles of drug metabolizing enzymes and transporters in the pathogenesis of DILI, aiming to identify predictors of liver injury. Olubamiwa has contributed to the development of databases, such as DILIrank 2.0, which compiles information on DILI risk based on regulatory labeling and scientific literature. This research is supported by collaborations with colleagues at the National Center for Toxicological Research, including Minjun Chen, Tsung‐Jen Liao, and Skylar Connor, with whom they have co-authored multiple publications. Olubamiwa's scholarship includes a h-index of 2 and 12 total citations across 3 publications.
Metrics
- h-index: 2
- Publications: 3
- Citations: 15
Selected Publications
-
DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review (2025)
-
Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury (2024)
Collaboration Network
Top Collaborators
Minjun Chen
National Center for Toxicological Research
3 shared publications
In database
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
Patrice Dehanne
RELX Group (Netherlands) (NL)
2 shared publications
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury
Catherine Noban
RELX Group (Netherlands) (NL)
2 shared publications
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury
Olivier Barberan
RELX Group (Netherlands) (NL)
2 shared publications
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury
Tsung‐Jen Liao
National Institutes of Health
1 shared publication
In database
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
Jinwen Zhao
University of Arkansas at Little Rock (US)
1 shared publication
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
Yeliz Angin
RELX Group (Netherlands) (NL)
1 shared publication
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
Jingyi Ma
Food and Drug Administration (TH)
1 shared publication
- Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury
Yeliz Angın
RELX Group (Netherlands) (NL)
1 shared publication
- Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury
Yanyan Qu
National Center for Toxicological Research (US)
1 shared publication
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
Skylar Connor
National Center for Toxicological Research
1 shared publication
In database
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
Weida Tong
National Center for Toxicological Research (US)
1 shared publication
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
Dongying Li
National Center for Toxicological Research
1 shared publication
In database
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
Similar Researchers
Based on overlapping research topics
Jade N. Hess
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Metabolism and Genetic Disorders
J.H. Seo
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Meta-analysis and systematic reviews
Bridgett Knox
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Metabolism and Genetic Disorders
G AKERMAN
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Metabolism and Genetic Disorders
Kristin Ashby
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Metabolism and Genetic Disorders
H. J. Chen
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Metabolism and Genetic Disorders